Logo image of PLSE

PULSE BIOSCIENCES INC (PLSE) Stock Price, Quote, News and Overview

NASDAQ:PLSE - Nasdaq - US74587B1017 - Common Stock - Currency: USD

15.1  -0.55 (-3.51%)

After market: 15.1 0 (0%)

PLSE Quote, Performance and Key Statistics

PULSE BIOSCIENCES INC

NASDAQ:PLSE (7/18/2025, 8:04:08 PM)

After market: 15.1 0 (0%)

15.1

-0.55 (-3.51%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High25
52 Week Low13.5
Market Cap1.02B
Shares67.27M
Float17.52M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-06 2025-08-06
IPO05-18 2016-05-18


PLSE short term performance overview.The bars show the price performance of PLSE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

PLSE long term performance overview.The bars show the price performance of PLSE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 200 400 600 800

The current stock price of PLSE is 15.1 USD. In the past month the price increased by 0.33%. In the past year, price decreased by -5.39%.

PULSE BIOSCIENCES INC / PLSE Daily stock chart

PLSE Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.24 215.17B
ISRG INTUITIVE SURGICAL INC 67.88 185.88B
BSX BOSTON SCIENTIFIC CORP 38.39 153.33B
SYK STRYKER CORP 31.08 148.81B
MDT MEDTRONIC PLC 16.29 114.81B
BDX BECTON DICKINSON AND CO 12.69 51.26B
EW EDWARDS LIFESCIENCES CORP 29.42 44.87B
IDXX IDEXX LABORATORIES INC 45.14 41.38B
RMD RESMED INC 28.41 37.82B
GEHC GE HEALTHCARE TECHNOLOGY 16.51 34.78B
DXCM DEXCOM INC 50.84 32.89B
PHG KONINKLIJKE PHILIPS NVR- NY 15.38 23.69B

About PLSE

Company Profile

PLSE logo image Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. The company is headquartered in Hayward, California and currently employs 75 full-time employees. The company went IPO on 2016-05-18. The Company’s CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The company is pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation (AF) and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Its nsPFA Percutaneous Electrode System consists of a disposable, percutaneous, needle electrode for use with its CellFX Console. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment of AF. The CellFX Console is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. The company is also developing a Nanosecond PFA 360-degree Cardiac Catheter System.

Company Info

PULSE BIOSCIENCES INC

3957 Point Eden Way

Hayward CALIFORNIA 94545 US

CEO: Darrin R. Uecker

Employees: 75

PLSE Company Website

PLSE Investor Relations

Phone: 15109064600

PULSE BIOSCIENCES INC / PLSE FAQ

What is the stock price of PULSE BIOSCIENCES INC today?

The current stock price of PLSE is 15.1 USD. The price decreased by -3.51% in the last trading session.


What is the ticker symbol for PULSE BIOSCIENCES INC stock?

The exchange symbol of PULSE BIOSCIENCES INC is PLSE and it is listed on the Nasdaq exchange.


On which exchange is PLSE stock listed?

PLSE stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for PULSE BIOSCIENCES INC stock?

6 analysts have analysed PLSE and the average price target is 22.44 USD. This implies a price increase of 48.61% is expected in the next year compared to the current price of 15.1. Check the PULSE BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PULSE BIOSCIENCES INC worth?

PULSE BIOSCIENCES INC (PLSE) has a market capitalization of 1.02B USD. This makes PLSE a Small Cap stock.


How many employees does PULSE BIOSCIENCES INC have?

PULSE BIOSCIENCES INC (PLSE) currently has 75 employees.


What are the support and resistance levels for PULSE BIOSCIENCES INC (PLSE) stock?

PULSE BIOSCIENCES INC (PLSE) has a support level at 15.08 and a resistance level at 15.84. Check the full technical report for a detailed analysis of PLSE support and resistance levels.


Should I buy PULSE BIOSCIENCES INC (PLSE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PULSE BIOSCIENCES INC (PLSE) stock pay dividends?

PLSE does not pay a dividend.


When does PULSE BIOSCIENCES INC (PLSE) report earnings?

PULSE BIOSCIENCES INC (PLSE) will report earnings on 2025-08-06.


What is the Price/Earnings (PE) ratio of PULSE BIOSCIENCES INC (PLSE)?

PULSE BIOSCIENCES INC (PLSE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.97).


What is the Short Interest ratio of PULSE BIOSCIENCES INC (PLSE) stock?

The outstanding short interest for PULSE BIOSCIENCES INC (PLSE) is 14.29% of its float. Check the ownership tab for more information on the PLSE short interest.


PLSE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PLSE. When comparing the yearly performance of all stocks, PLSE is a bad performer in the overall market: 85.11% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PLSE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PLSE. PLSE has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PLSE Financial Highlights

Over the last trailing twelve months PLSE reported a non-GAAP Earnings per Share(EPS) of -0.97. The EPS decreased by -19.63% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -45.17%
ROE -50.86%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-21.43%
Sales Q2Q%N/A
EPS 1Y (TTM)-19.63%
Revenue 1Y (TTM)N/A

PLSE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to PLSE. The Buy consensus is the average rating of analysts ratings from 6 analysts.


Ownership
Inst Owners8.65%
Ins Owners72.7%
Short Float %14.29%
Short Ratio14.01
Analysts
Analysts43.33
Price Target22.44 (48.61%)
EPS Next Y-20%
Revenue Next YearN/A